Technical Analysis for MCRPF - Microport Scientific

Grade Last Price % Change Price Change
grade A 2.275 -3.60% -0.0850
MCRPF closed down 3.6 percent on Friday, March 27, 2020, on 50 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical MCRPF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
New 52 Week Closing High Bullish -3.60%
Wide Bands Range Expansion -3.60%
Gapped Up Strength -3.60%
1,2,3 Pullback Bullish Bullish Swing Setup 13.75%
Boomer Buy Setup Bullish Swing Setup 13.75%
Older signals for MCRPF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

MicroPort is making the world a better place one patient at a time. In fact, for every 20 seconds that pass, on average, one patient somewhere in the world has life saving, or quality of life improving medical intervention, using MicroPort products. Our company is all about improving human life through the practical application of innovative science. And our aim is to continually develop leading technologies and products for physicians, with life-saving solutions and treatments for patients. We are a young company with an ambition to establish MicroPort as a globally recognised brand name. Yet as the business grows, we strive to retain our unique entrepreneurial spirit. We continue to demonstrate entrepreneurial achievement and innovation coupled with our commitment to improving the social wellbeing. We work in close cooperation with recognized international physicians and scientists worldwide, to develop a range of products that meet the highest quality and clinical standards. We develop, and produce an ever diversifying portfolio of products cover a wide range of business segments including Cardiovascular Devices, Orthopedic Devices, Diabetes Care and Endocrinal Management, Electrophysiological Devices, Endovascular Devices, Neurovascular Devices, Surgical Management and others. We are dedicated to make a patient oriented global enterprise focusing on minimally invasive and other emerging medical technologies. Our products touch the lives of many people every day and we take this important responsibility very seriously. We are proud that MicroPort products will always achieve the highest standards of quality and ensure improved health for the patient. We know our products offer hope and relief to many people around the world, and every one of our employees takes personal responsibility to achieve our vision. Today our products are used to save lives and improve patient health in hospitals throughout China and we export our products to regions all over the world, including America and Europe. Our company has a large and growing intellectual property portfolio and the strongest research and development team in China's medical device sector. The applied expertise of our R&D team ensures our latest products are always innovative, as we strive to provide state of the art medical technologies and deliver the next generation of medical devices and treatments for chronic ailments. Central to this innovative approach is the inspiration provided by nature and our appreciation for the beauty of human biology. And it is our commercial achievements which enable us to give something back to the society which makes our success possible. Our commitment to social engagement and responsibility is an important aspect of our company culture and philosophy. MicroPort works diligently to build strong relationships with all our international partners and all our stakeholders, because as a Corporation, we think our community is an essential part of our business, and we strive to help in the best ways we can.
Medical Device Diabetes Care Medical Technologies

Is MCRPF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 2.41
52 Week Low 0.4444
Average Volume 4,024
200-Day Moving Average 1.1119
50-Day Moving Average 1.2733
20-Day Moving Average 1.6649
10-Day Moving Average 2.0375
Average True Range 0.1464
ADX 37.71
+DI 56.7768
-DI 27.2341
Chandelier Exit (Long, 3 ATRs ) 1.9708
Chandelier Exit (Short, 3 ATRs ) 1.5092
Upper Bollinger Band 2.4983
Lower Bollinger Band 0.8315
Percent B (%b) 0.87
BandWidth 100.1141
MACD Line 0.2899
MACD Signal Line 0.2349
MACD Histogram 0.055
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.2750
Resistance 3 (R3) 2.2750 2.2750 2.2750
Resistance 2 (R2) 2.2750 2.2750 2.2750 2.2750
Resistance 1 (R1) 2.2750 2.2750 2.2750 2.2750 2.2750
Pivot Point 2.2750 2.2750 2.2750 2.2750 2.2750
Support 1 (S1) 2.2750 2.2750 2.2750 2.2750 2.2750
Support 2 (S2) 2.2750 2.2750 2.2750 2.2750
Support 3 (S3) 2.2750 2.2750 2.2750
Support 4 (S4) 2.2750